THOMPSON DAVIS & CO., INC. - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 137 filers reported holding CARA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.35 and the average weighting 0.5%.

Quarter-by-quarter ownership
THOMPSON DAVIS & CO., INC. ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2018$22,000
+1000.0%
900
+620.0%
0.05%
+860.0%
Q2 2018$2,0001250.01%
Other shareholders
CARA THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Chescapmanager LLC 1,702,110$439,1440.04%
DISCIPLINED GROWTH INVESTORS INC /MN 1,935,718$499,4150.01%
ADAR1 Capital Management, LLC 159,469$41,1430.01%
Y-Intercept (Hong Kong) Ltd 414,731$107,0010.01%
FARALLON CAPITAL MANAGEMENT LLC 1,556,251$401,5130.00%
Virtu Financial LLC 75,987$200.00%
Corsair Capital Management 19,864$5,1250.00%
WEALTH EFFECTS LLC 13,500$3,4830.00%
Cypress Capital Management LLC (WY) 5,000$1,2900.00%
Citadel Advisors 5,000$1,2900.00%
View complete list of CARA THERAPEUTICS INC shareholders